Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Intravenous administration of allogeneic Wharton jelly–derived mesenchymal stem cells for treatment of dogs with congestive heart failure secondary to myxomatous mitral valve disease

American Journal of Veterinary Research(2021)10.2460/ajvr.82.6.487Source: DataRank Database

Intravenous administration of allogeneic Wharton jelly–derived mesenchymal stem cells for treatment of dogs with congestive heart failure secondary to myxomatous mitral valve disease is a research paper published in American Journal of Veterinary Research (2021). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 1.16)OA: bronzeTopics (26)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Dawn M. Meola,Airiel M. Davis,Bruce Barton ORCID,Andrew M. Hoffman ORCID,Vicky K. Yang ORCID

Live enrichment

PubMed:34032485 PMC:PMC8224903 OpenAlex:https://openalex.org/W3165450829

NIH HHS

Grant: K01 OD028205

FWCI

1.16

Citation Percentile

0.8%

Citation Trend

2021

2022

2023

2024

2025

bronze

journalhttps://avmajournals.avma.org/downloadpdf/journals/ajvr/82/6/ajvr.82.6.487.pdf

publisherhttps://avmajournals.avma.org/downloadpdf/journals/ajvr/82/6/ajvr.82.6.487.pdf

publisherhttps://avmajournals.avma.org/view/journals/ajvr/82/6/ajvr.82.6.487.xml

publisherhttps://avmajournals.avma.org/downloadpdf/journals/ajvr/82/6/ajvr.82.6.487.xml

journalhttps://doi.org/10.2460/ajvr.82.6.487

Fields of Study

Mesenchymal stem cell researchCardiovascular Conditions and TreatmentsVeterinary Orthopedics and Neurology

MeSH Terms

AnimalsDog DiseasesDogsPharmaceutical PreparationsHeart FailureMitral ValveHematopoietic Stem Cell TransplantationMesenchymal Stem CellsWharton JellyAdministration, Intravenous

Keywords

MedicineHeart failureMesenchymal stem cellCD90Internal medicineCardiac function curveWharton's jellyCardiologySurgeryGastroenterologyCD34Stem cellPathology

Sustainable Development Goals

SDG 0: Good health and well-being

Intravenous administration of allogeneic Wharton jelly–derived mesenchymal stem cells for treatment of dogs with congestive heart failure secondary to myxomatous mitral valve disease

FAIR Checklist

Authors (5)

Funding (1 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)